744 related articles for article (PubMed ID: 28044932)
1. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
2. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
3. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
[TBL] [Abstract][Full Text] [Related]
4. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VH; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar HJ;
Clin Pharmacol Ther; 2017 Mar; 101(3):341-358. PubMed ID: 28027596
[TBL] [Abstract][Full Text] [Related]
5. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
[TBL] [Abstract][Full Text] [Related]
7. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
9. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
11. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
[TBL] [Abstract][Full Text] [Related]
13. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
[TBL] [Abstract][Full Text] [Related]
14. Integrating pharmacogenomics into electronic health records with clinical decision support.
Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
Kirchheiner J; Fuhr U; Brockmöller J
Nat Rev Drug Discov; 2005 Aug; 4(8):639-47. PubMed ID: 16056390
[TBL] [Abstract][Full Text] [Related]
16. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
[TBL] [Abstract][Full Text] [Related]
17. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
[TBL] [Abstract][Full Text] [Related]
19. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
20. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
Amara N; Blouin-Bougie J; Bouthillier D; Simard J
Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
